SEC Form 4 · accession 0001209191-15-030956
Cascadian Therapeutics, Inc. · CASC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Daniel K Spiegelman
Director
Period of report
Mar 25, 2015
Accepted (ET)
Apr 1, 2015 · 7:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412067
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 25, 2015 | P | 10,000 | $1.6271 | A | 30,644 | D | |
| Common Stock | Mar 26, 2015 | P | 10,000 | $1.5856 | A | 40,644 | D |
Table II — derivative securities
No Table II lines on this filing.